Last Updated: June 24, 2026

Suppliers and packagers for prezcobix

✉ Email this page to a colleague

prezcobix

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Janssen Prods	PREZCOBIX	cobicistat; darunavir ethanolate	TABLET;ORAL	205395	NDA	A-S Medication Solutions	50090-1723-0	30 TABLET, FILM COATED in 1 BOTTLE (50090-1723-0)	2015-01-31
Janssen Prods	PREZCOBIX	cobicistat; darunavir ethanolate	TABLET;ORAL	205395	NDA	Janssen Products, LP	59676-575-30	30 TABLET, FILM COATED in 1 BOTTLE (59676-575-30)	2015-01-31
Janssen Prods	PREZCOBIX	cobicistat; darunavir ethanolate	TABLET;ORAL	205395	NDA	Janssen Products, LP	59676-578-30	30 TABLET, FILM COATED in 1 BOTTLE (59676-578-30)	2025-03-21
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>NDA/ANDA	>Supplier	>Package Code	>Package	>Marketing Start

Prezcobix Suppliers (Gilead) Overview: Manufacturing, API, and Contract Manufacturing Footprint

Last updated: May 28, 2026

Executive summary: Public supplier disclosures for Prezcobix (darunavir/cobicistat) tablets are primarily constrained to Gilead Sciences branded manufacturing listings and limited regulatory-facing information. The most decision-relevant “supplier” view for diligence is: (1) the Orange Book/NDA manufacturing site data that identifies finished-dose manufacturers, (2) API and intermediate supply often indirectly evidenced via DMF cross-references in FDA filings, and (3) contract manufacturing that typically appears at the finished-dose level rather than as named API vendors in public databases.

Result: A complete supplier map that names specific API suppliers (and not only finished-dose manufacturers) for darunavir and cobicistat cannot be produced from the information provided in this request.

More… ↓

⤷ Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.